CDK2AP1 and glioma: Although the majority of existing reports support the role of CDK2AP1 to be a tumor suppressor, recent studies have shown that knockdown of CDK2AP1 in human glioma cells reduced proliferation, caused a G0/G1 cell cycle arrest and increased apoptosis [7].